Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:    
Net loss $ (61,104) $ (59,601)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,701 253
Amortization of debt discounts and issuance costs   3,740
Issuance of warrants 207 5,790
Write-off of debt discounts and debt issuance costs at IPO   10,132
Change in fair value of warrant liability (184) (7,114)
Provision for doubtful accounts 27 107
Stock-based compensation expense 15,493 16,089
Changes in assets and liabilities:    
Accounts receivable (15,531) (2,964)
Expenditures billable to clients 1,468 (779)
Prepaid expenses and other current assets (594) (1,620)
Accounts payable 13,148 1,017
Accrued media payments 1,417 (778)
Client advances 6,162 1,636
Other accrued liabilities (7,823) 2,181
Other liabilities 1,386  
Net cash used in operating activities (42,227) (31,911)
Cash flows from investing activities:    
Purchases of marketable securities   (39,850)
Proceeds from sales of marketable securities 26,000  
Purchases of property, equipment and leasehold improvements (3,718) (664)
Licensing and purchase of software (570) (3,034)
Acquisition of businesses, net of cash acquired (5,783)  
Deposits for operating leases   (779)
Net cash provided by (used in) investing activities 15,929 (44,327)
Cash flows from financing activities:    
Proceeds from common stock offerings, net 32,770 56,468
Proceeds from exercise of Primary Warrant   29,263
Proceeds received under the Bridge Loan Agreement   8,000
Proceeds from issuances of stock under employee stock plans 1,558 131
Debt issuance costs   (68)
Other (36) (89)
Net cash provided by financing activities 34,292 93,705
Net increase in cash and cash equivalents 7,994 17,467
Cash and cash equivalents, beginning of period 29,545 12,078
Cash and cash equivalents, end of period 37,539 29,545
Cash paid during periods for:    
Taxes paid 6 6
Non-cash investing and financing activities:    
Conversion of convertible notes payable, including accrued interest, to common stock   28,782
Conversion of redeemable convertible preferred stock to common stock   27,266
Unpaid deferred common stock offering costs   $ 126
Shares issued for acquisition of businesses $ 10,128